Latest / EMJ Podcast: Insights For Healthcare Professionals
Sex Differences in Alzheimer's Disease: Risk Factors and Biomarkers
In this first deep dive, Rachel Buckley joins host Catherine Glass to explore how Alzheimer's disease risk can be detected before symptoms appear. From blood-based biomarkers like p-tau217, to AI-driven models of cognitive resilience, the episode examines how risk, progression, and protection can be better understood and predicted over time.
Timestamps:
00:00:57:11 – Phosphorylated tau and amyloid-PET
00:08:15:05 – Biomarkers, risk, and progression
00:11:18:04 – Brain resistance and cognitive resilience
00:15:23:23 – AI biases
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.